Interferon-αtherapy for chronic hepatitis C in special patient populations
✍ Scribed by Patrick Marcellin; Nathalie Boyer; Jean-Pierre Behamou; Serge Erlinger
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 573 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive
## Abstract In interferon treatment of chronic hepatitis C patients, the biochemical and virological responses mostly parallel each other. However, some patients who show persistent ALT normalization display continued viremia after cessation of therapy. High‐density hepatitis C virus (HCV) particle
Sustained responses to interferon-alpha occur in 10% to 25% of patients with chronic hepatitis C, but the long-term outcome is not well defined. We evaluated the long-term clinical, histological, and virological outcomes of 10 patients with chronic hepatitis C who were treated between 1984 and 1987